Abstract

For several years now, the College of American Pathologists (CAP) and the American Society for Reproductive Medicine (ASRM) have collaborated to accredit assisted reproductive technology (ART) laboratories. The purpose of this collaboration is to comply with the Clinical Laboratory Improvement Act of 1988 (CLIA ’88), that permits CAP to accredit laboratories through an inspection process with standards as rigid or even more rigid than laboratories inspected by the Clinical Laboratory Inspection Agency (CLIA) affiliated with the Health Care Finance Administration (HCFA) (1), although only CLIA can certify a clinical laboratory, perform complaint inspections, fine, sanction, or close down a clinical laboratory (1). Only the states of Washington, Oregon, and New York are CLIA-exempt, in which case a CLIA-authorized state agency performs these functions (1).

Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.